...
首页> 外文期刊>NeuroImage: Clinical >Multicenter stability of resting state fMRI in the detection of Alzheimer's disease and amnestic MCI
【24h】

Multicenter stability of resting state fMRI in the detection of Alzheimer's disease and amnestic MCI

机译:静息状态功能磁共振成像在检测阿尔茨海默氏病和遗忘性MCI中的多中心稳定性

获取原文

摘要

Background In monocentric studies, patients with mild cognitive impairment (MCI) and Alzheimer's disease (AD) dementia exhibited alterations of functional cortical connectivity in resting-state functional MRI (rs-fMRI) analyses. Multicenter studies provide access to large sample sizes, but rs-fMRI may be particularly sensitive to multiscanner effects. Methods We used data from five centers of the “German resting-state initiative for diagnostic biomarkers” ( psymri.org ), comprising 367 cases, including AD patients, MCI patients and healthy older controls, to assess the influence of the distributed acquisition on the group effects. We calculated accuracy of group discrimination based on whole brain functional connectivity of the posterior cingulate cortex (PCC) using pooled samples as well as second-level analyses across site-specific group contrast maps. Results We found decreased functional connectivity in AD patients vs. controls, including clusters in the precuneus, inferior parietal cortex, lateral temporal cortex and medial prefrontal cortex. MCI subjects showed spatially similar, but less pronounced, differences in PCC connectivity when compared to controls. Group discrimination accuracy for AD vs. controls (MCI vs. controls) in the test data was below 76% (72%) based on the pooled analysis, and even lower based on the second level analysis stratified according to scanner. Only a subset of quality measures was useful to detect relevant scanner effects. Conclusions Multicenter rs-fMRI analysis needs to employ strict quality measures, including visual inspection of all the data, to avoid seriously confounded group effects. While pending further confirmation in biomarker stratified samples, these findings suggest that multicenter acquisition limits the use of rs-fMRI in AD and MCI diagnosis. Highlights ? Diagnostic accuracy of multicenter rs-fMRI in AD and MCI ? Quality metrics for multicenter rs-fMRI that should be used ? Quality metrics for multicenter rs-fMRI that should not be used ? Multicenter rs-fMRI will have limited diagnostic use in clinical routine diagnosis.
机译:背景技术在单中心研究中,患有轻度认知障碍(MCI)和阿尔茨海默氏病(AD)痴呆的患者在静息状态功能MRI(rs-fMRI)分析中表现出功能性皮质连接的改变。多中心研究提供了获取大样本量的途径,但是rs-fMRI对多扫描仪效应可能特别敏感。方法我们使用来自“德国静止状态诊断生物标志物倡议”(psymri.org)五个中心的数据(包括367例AD患者,MCI患者和健康的老年对照),评估了分布式采集对肝癌的影响。小组效应。我们基于后扣带回皮层(PCC)的全脑功能连通性,使用合并样本以及针对特定地点的组对比图进行的第二级分析,计算了组区分的准确性。结果我们发现AD患者与对照组的功能连接性降低,包括前神经簇,顶下皮质,颞外侧皮质和额前内侧皮质。与对照组相比,MCI受试者在PCC连接性上表现出空间上相似但不明显的差异。根据汇总分析,测试数据中AD与对照(MCI与对照)的组区分准确度低于76%(72%),而根据根据扫描仪进行分层的第二级分析,甚至更低。质量测量的子集仅可用于检测相关的扫描仪效果。结论多中心rs-fMRI分析需要采取严格的质量措施,包括对所有数据进行目测检查,以避免严重混淆的小组效应。尽管有待在生物标志物分层样品中进一步确认,但这些发现表明,多中心采集限制了rs-fMRI在AD和MCI诊断中的应用。强调 ?多中心rs-fMRI在AD和MCI中的诊断准确性应使用多中心rs-fMRI的质量指标?多中心rs-fMRI的质量指标不应该使用?多中心rs-fMRI在临床常规诊断中的诊断用途有限。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号